statcounter

Friday, May 3, 2013

China approved to respond to the H7N9 new drugs for influenza in critically ill patients



2013 on May 03, 2011 - 13:36
Print Abstract error correction Mall recommended font size Share

National Health and Family Planning Commission released the information of human infection with the H7N9 avian influenza outbreak. April 17 to April 17, the new report two cases of confirmed cases of H7N9 avian influenza infection. 2 new cases are from Shanghai, is active treatment, all close contacts found no abnormalities. As at 17:00 on the 6th, the country reported a total of 18 confirmed cases, including 6 deaths. The cases were distributed in Shanghai (8 cases, death four cases), Jiangsu (6 cases), Anhui (1), Zhejiang (3 cases, 2 deaths) in 4 Provinces. Found no epidemiological link between the confirmed cases, all close contacts of the cases have been measures to be taken under medical observation, no abnormality is found. The present situation in the dissemination of state, have not yet found the person to person. 6, Shanghai, Nanjing, Hangzhou total suspension of live poultry trade.

In response to the epidemic, the State Food and Drug Administration for regulatory approval of the anti-influenza drug peramivir sodium chloride injection. This is a new type of antiviral drugs for influenza, the existing clinical trial data to prove its influenza A and B. H7N9 is a subtype of the influenza A virus. China is the approval of the United States, Japan, South Korea and a few other peramivir one of the countries listed. Peramivir sodium chloride injection is the first intravenous administration of neuraminidase inhibitors for those patients with severe influenza can not be treated with inhaled or oral neuraminidase inhibitors in patients with other neurological neuraminidase inhibitors poor efficacy or provide a new treatment option for patients resistant. Currently, as a neuraminidase inhibitor class of drugs, China approved the listing of the Austrian Secretary phosphate oseltamivir the tablets and zanamivir inhalation.

6 am, convened by the National Health and Family Planning Organization of human infection with the H7N9 avian flu defense associate....http://news.0898.net/n/2013/0503/c231184-18587248.html